All articles by Vemula Pravalika
Vemula Pravalika
PCR rapid test for 3 important gastroenteritis pathogens for Vivalytic by Bosch now available
Bosch Healthcare Solutions has introduced a new PCR test for C. difficile, norovirus, and rotavirus, expanding the Vivalytic analysis platform’s capabilities to include gastroenteritis. This innovative test can simultaneously and automatically detect these 3 major diarrhea pathogens in under an hour right on site. Unlike previous tests that either included these pathogens in a larger panel or tested for each individually, this triple test is the first of its kind. The new Vivalytic test is available through distribution partners such as Randox Laboratories and R-Biopharm. “We developed this test so that medical practices and clinics can identify the cause of gastroenteritis more quickly and respond appropriately: with the right treatment and measures to prevent further spread and infection,” explains Marc Meier, president of Bosch Healthcare Solutions. Due to transportation and limited test availability, the complete detection of C. difficile can take up to several days.
Kerecis Expands Silicone Fish-Skin Combination Product Range with Shield Spiral, Offering Advanced Customizable Wound Care Solutions
Kerecis, the company pioneering the use of sustainably sourced fish skin and fatty acids in cellular therapy and tissue regeneration and protection, today announced the availability of Shield Spiral, an extension of the Kerecis Shield silicon fish-skin combination product range.
QIAGEN welcomes new U.S. guidelines for use of QuantiFERON-TB Gold Plus in detecting tuberculosis infections in children
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that it welcomes new guidelines in the United States that recommend screening at-risk children of all ages for latent tuberculosis (TB) infection with modern blood-based tests such as QIAGEN’s market-leading QuantiFERON-TB Gold Plus (QFT-Plus).
bioMérieux receives U.S. FDA Special 510(k) clearance and CLIA-waiver for its BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel Mini
bioMérieux, a world leader in the field of in vitro diagnostics, today announces that its BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel Mini has received U.S. Food and Drug Administration (FDA) Special 510(k) clearance and CLIA-waiver (Clinical Laboratory Improvement Amendments).
Cytovale’s FDA-Cleared Sepsis Diagnostic Triages First 5,000 Patients, Paves Way to New Hospital Protocols for Sepsis Management
First hospital to implement Cytovale’s IntelliSep® sepsis diagnostic tool realizes significant clinical and financial returns in first nine months of screening
Echo Hospice Receives Prestigious Center of Excellence Award from The Wound Pros
Leader in compassionate care honored for excellence in wound healing and dedication to community
Healcisio Receives Phase II STTR Funding to Continue Critical Care AI Research
Healcisio, a leader in AI and digital healthcare, announces it has received a $1 Million STTR Phase II award from the NIAID to advance the development of its critical care decision support platform and a new AI-powered software suite for abstracting and reporting quality measures.
Noul Participates in a Malaria Project Initiated by U.S. CDC with Kenya Medical Research Institute
On-Device AI healthcare company, Noul, announced that it will jointly participate in a malaria diagnosis project initiated by U.S. Centers for Disease Control and Prevention (CDC) with the Kenya Medical Research Institute (KEMRI).
Bio-Rad Extends Range of Anti-Biotherapeutic Antibodies to Accelerate Antibody Drug Development
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today launched four new anti-idiotypic antibodies to the following drugs: atezolizumab (Lemtrada), avelumab (Bavencio), obinutuzumab (Gazyvaro), and ocrelizumab (Ocrevus), extending its range of anti-biotherapeutic antibodies. The company also introduced its anti-monomethyl auristatin E (MMAE) biotherapeutic antibody range for bioanalysis.
Microbix Hosts Minister Nina Tangri to Open Capacity Expansions
Adds Product Development & QC Labs, Fully-Automated IVD Vial-Filling Capability